Sector: Health Care | Focus: Life Sciences Tools & Services
HQ: Columbus, Ohio
Financial Risks
The company faces risks from soft market demand, particularly in China. Economic uncertainty, including potential recession, and geopolitical events (Ukraine, Middle East) pose risks. Fluctuations in currency exchange rates (Swiss franc, euro, Chinese renminbi) negatively impact earnings. Changes in global market conditions could reduce cash flow. The company's debt levels can fluctuate due to exchange rate changes.
Financial Upside
The company experienced increased net sales in Europe and Asia/Rest of World (excluding China) in local currencies. Service revenue increased. Laboratory product sales grew. Margin expansion and cost savings initiatives are expected to improve profitability. A non-cash discrete tax benefit from a tax audit settlement is a positive. The company has a significant share repurchase program with remaining availability.
